Agilent Technologies, Inc. is a global leader in life sciences, diagnostics and applied chemical markets. Headquartered in Santa Clara, California, the company designs and manufactures analytical instruments, software, services and consumables for laboratories engaged in pharmaceutical R&D, clinical diagnostics, food safety, environmental testing and chemical analysis. Agilent’s core offerings include chromatography systems, mass spectrometers, spectroscopic analyzers, microarrays, reagents and laboratory automation solutions.
Formed in 1999 as a spin-off from Hewlett-Packard’s scientific instruments business, Agilent has expanded its portfolio through targeted acquisitions and organic innovation. In 2014 the company completed the separation of its electronic measurement segment to create Keysight Technologies, allowing Agilent to focus exclusively on the life sciences and diagnostics markets. Subsequent acquisitions and internal R&D have bolstered capabilities in genomics, cell analysis and lab informatics.
Agilent serves a broad array of customers across more than 100 countries, operating in the Americas, Europe, Middle East and Africa, and the Asia-Pacific region. Its products support applications ranging from drug discovery and biopharmaceutical production to environmental monitoring, food safety testing and semiconductor materials analysis. The company maintains regional application laboratories, customer support centers and distribution networks to ensure technical service and rapid deployment of solutions worldwide.
Under the leadership of President and Chief Executive Officer Michael R. McMullen, Agilent continues to pursue growth in high-value markets by advancing measurement science and enabling laboratories to improve productivity and data quality. The company’s commitment to innovation and customer collaboration positions it as a key partner for organizations seeking to address complex challenges in healthcare, sustainability and technology development.
AI Generated. May Contain Errors.
